Zoetis Inc
ZTSCompany Overview
Zoetis, Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health technology. The firm operates through the United States and International geographical segments. The United States segment is involved in U.S. market and regulatory activities. The International segment includes non-U.S. market and regulatory activities. The company was founded in 1952 and is headquartered in Parsippany, NJ.
Country
US
Market Cap
$89.05B
Last Fiscal Year
2023
Final Shariah Status
Failed
Compliance Analysis Overview
Shariah Compliance Benchmarks:
- Business Compliance: Non-Shariah compliant revenue must be less than 5% of total revenue
- Liabilities Compliance: Interest-bearing debt must be less than 33% of market capitalization
Business Compliance
65.85%
failed
Liabilities Compliance
7.58%
passed
Final Shariah Status
Failed
This stock does not meet all Shariah compliance criteria according to AAOIFI standards.
Stock Information
| Name | Zoetis Inc |
| Ticker | ZTS |
| Main Business | Drug Manufacturers - Specialty & Generic |
| Type | Common Stock |
| Industry | Drug Manufacturers - Specialty & Generic |
| Country | US |
| Market Cap | $89.05 B |
Shariah Analysis Breakdown
Business compliance Breakdown
| Revenue Segment | Value ($M) | Non-Compliant ($M) | Reason |
|---|---|---|---|
| Revenue | $808.0 | $565.0 | pork related |
| Interest income | $50.0 | $0.0 | - |
| Total | $858.0 | $565.0 | 65.85% (failed) |
Liabilities Compliance Breakdown
| Liability Item | Value ($M) | % of Market Cap |
|---|---|---|
| current debt and capital lease obligation | $3,000,000.0 | 0.00% |
| long term debt and capital lease obligation | $6,750,000,000.0 | 7.58% |
| Total Interest-Bearing Debt | $6,753,000,000.0 | 7.58% |
| Market Capitalization | $89,047,422,900.0 | 100.00% |
| Compliance Status | Threshold: 33% | passed |